Harnessing the potential of epigenetic therapy to target solid tumors
Author:
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Reference129 articles.
1. The future of epigenetic therapy in solid tumours—lessons from the past
2. A decade of exploring the cancer epigenome — biological and translational implications
3. Cancer Epigenetics: From Mechanism to Therapy
4. Cancer epigenomics: beyond genomics
5. Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity;Journal of Medicinal Chemistry;2024-09-12
2. Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023;Frontiers in Pharmacology;2024-09-12
3. The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level;Biomolecules;2024-09-04
4. Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology;Current Issues in Molecular Biology;2024-06-27
5. N6-methyladenosine modification and post-translational modification of epithelial–mesenchymal transition in colorectal cancer;Discover Oncology;2024-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3